Source:http://linkedlifedata.com/resource/pubmed/id/11978635
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2002-4-29
|
pubmed:abstractText |
Apoptosis via Fas/Fas ligand (FasL) interactions has been proposed to be a major T-cell-mediated effector mechanism in autoimmune diabetes. To elucidate the role of Fas/FasL interactions in NOD diabetes, the effects of neutralizing anti-FasL antibody on autoimmune responses were evaluated. Islet-specific CD8(+) and CD4(+) T-cells expressed FasL upon activation and mediated FasL-dependent cytotoxicity against Fas-expressing target cells in vitro, although their cytotoxicity against islet cells was not blocked by anti-FasL antibody. Moreover, administration of anti-FasL antibody failed to inhibit diabetes in vivo in the CD8(+) T-cell adoptive transfer model. On the other hand, blockade of Fas/FasL interactions significantly inhibited CD4(+) T-cell-dependent diabetes in adoptive transfer models. These results suggest a substantial contribution of Fas/FasL interactions to CD4(+), but not CD8(+), T-cell-mediated destruction of pancreatic beta-cells. When anti-FasL antibody was administered to NOD mice between 5 and 15 weeks of age, the onset of diabetes was slightly delayed but the incidence was not decreased. However, administration of anti-FasL antibody at 2-4 weeks of age completely prevented insulitis and diabetes. These results suggest that Fas/FasL interactions contribute to CD4(+) T-cell-mediated beta-cell destruction and play an essential role in the initiation of autoimmune NOD diabetes.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD95,
http://linkedlifedata.com/resource/pubmed/chemical/Fas Ligand Protein,
http://linkedlifedata.com/resource/pubmed/chemical/Fasl protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0012-1797
|
pubmed:author |
pubmed-author:ArisawaKenjiK,
pubmed-author:ChakrabartySagarikaS,
pubmed-author:ChowdhuryShahead AliSA,
pubmed-author:JinZhen ZiZZ,
pubmed-author:KasugaMasatoM,
pubmed-author:KotaniReikoR,
pubmed-author:NagataMasaoM,
pubmed-author:NakayamaMakiM,
pubmed-author:YagitaHideoH,
pubmed-author:YamadaKatsumiK,
pubmed-author:YasudaHisafumiH,
pubmed-author:YokonoKoichiK
|
pubmed:issnType |
Print
|
pubmed:volume |
51
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1391-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11978635-Adoptive Transfer,
pubmed-meshheading:11978635-Animals,
pubmed-meshheading:11978635-Antibodies,
pubmed-meshheading:11978635-Antigens, CD95,
pubmed-meshheading:11978635-CD4-Positive T-Lymphocytes,
pubmed-meshheading:11978635-CD8-Positive T-Lymphocytes,
pubmed-meshheading:11978635-Cytotoxicity Tests, Immunologic,
pubmed-meshheading:11978635-Diabetes Mellitus, Type 1,
pubmed-meshheading:11978635-Fas Ligand Protein,
pubmed-meshheading:11978635-Female,
pubmed-meshheading:11978635-Islets of Langerhans,
pubmed-meshheading:11978635-Male,
pubmed-meshheading:11978635-Membrane Glycoproteins,
pubmed-meshheading:11978635-Mice,
pubmed-meshheading:11978635-Mice, Inbred NOD
|
pubmed:year |
2002
|
pubmed:articleTitle |
Fas/Fas ligand interactions play an essential role in the initiation of murine autoimmune diabetes.
|
pubmed:affiliation |
Department of Diabetes, Digestive and Kidney Diseases, Kobe University Graduate School of Medicine, Kobe, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|